Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
MrWhy.com » Videos » FDA Rejects Pfizer Pain Drug, Partners Pain Therapeutics and
FDA Rejects Pfizer Pain Drug, Partners Pain Therapeutics and
FDA Rejects Pfizer Pain Drug,  Partners Pain Therapeutics and
Report
FDA Rejects Pfizer Pain Drug, Partners Pain Therapeutics and
The Food and Drug Administration has rejected a pain drug that is designed to discourage abuse, Pfizer (NYSE:PFE) and Pain Therapeutics (NASDAS:PTIE) announced today. The New York City-based Pfizer said the FDA has asked for more information about its pain drug, called Remoxy. In May, the company said approval could be delayed because of issues in the manufacturing section of the application, but it did not say today whether or not that was the reason for today’s decision. Shares of Pfizer's partners on Remoxy plummeted on the news. Pain Therapeutics is trading down 42% at $5.35 per share, while Durect Corp is trading down 27% at $2.24 per share. Shares of Pfizer are trading down 1.25% at $20.39.
Channel: Voxant Newsroom
Category: Business
Video Length: 0
Date Found: June 24, 2011
Date Produced: June 24, 2011
View Count: 0
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.